UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sensory aspects of Tourette syndrome

Neuroscience and biobehavioral reviews, 2018-05, Vol.88, p.170-176

2018

Volltextzugriff (PDF)

Aripiprazole for the treatment of Tourette syndrome

Expert review of neurotherapeutics, 2021-04, Vol.21 (4), p.381-391

2021

Volltextzugriff (PDF)

Social stigma and self-perception in adolescents with tourette syndrome

Adolescent health, medicine and therapeutics, 2019-06, Vol.10, p.75-82

2019

Volltextzugriff (PDF)

Irritability Symptoms in Gilles de la Tourette Syndrome

The journal of neuropsychiatry and clinical neurosciences, 2015, Vol.27 (1), p.42-47

2015

Volltextzugriff (PDF)

Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures

Neuropsychiatric disease and treatment, 2014-01, Vol.10 (default), p.2191-2200

2014

Volltextzugriff (PDF)

Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders

Pediatric health, medicine and therapeutics, 2016-01, Vol.7, p.57-64

2016

Volltextzugriff (PDF)

Telemedical education during national emergencies: learning from Kashmir

The clinical teacher, 2020-08, Vol.17 (4), p.415-417

2020

Volltextzugriff (PDF)

Audit of the management of the syphilis outbreak in Herefordshire 2011–2013

International journal of STD & AIDS, 2015-04, Vol.26 (5), p.357-359

2015

Volltextzugriff (PDF)

Zonisamide as a Treatment for Partial Epileptic Seizures: A Systematic Review

Advances in therapy, 2014-03, Vol.31 (3), p.276-288

2014

Volltextzugriff (PDF)

Clinical Guidelines on Long-Term Pharmacotherapy for Bipolar Disorder in Children and Adolescents

Journal of clinical medicine, 2014-01, Vol.3 (1), p.135-143

2014

Volltextzugriff (PDF)

Abstract PD5-02: Dcis as a risk lesion for invasive breast cancer and death from other cancers

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD5-02-PD5-02

2021

Volltextzugriff (PDF)

Trypanosoma brucei Plasma Membrane-Type Ca2+-ATPase 1 (TbPMC1) and 2 (TbPMC2) Genes Encode Functional Ca2+-ATPases Localized to the Acidocalcisomes and Plasma Membrane, and Essential for Ca2+ Homeostasis and Growth

The Journal of biological chemistry, 2004-04, Vol.279 (14), p.14427-14439

2004

Volltextzugriff (PDF)

Breaking the Stigma: Major Depressive Disorder

Cox, Joanna

2019

Volltextzugriff (PDF)

Abstract CT073: IMPRIME 1 (NCT02981303): A novel phase 2 study in second-line +, metastatic triple negative breast cancer patients shows promising clinical benefit for the combination of the immune checkpoint inhibitor, pembrolizumab (pembro), with the novel innate immune activator, Imprime PGG

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT073-CT073

2020

Volltextzugriff (PDF)

The prevalence of growth hormone deficiency in survivors of subarachnoid haemorrhage: results from a large single centre study

Pituitary, 2017-12, Vol.20 (6), p.624-634

2017

Volltextzugriff (PDF)

Abstract PD1-02: Response and clinical benefit assessment of the combination of the dectin-1 agonist imprime PGG and anti-PD-1 pembrolizumab in chemotherapy-resistant metastatic triple negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.PD1-02-PD1-02

2020

Volltextzugriff (PDF)

The Biggest Difference in your Child’s Day: Parent-Identified Communication Challenges Experienced by their Children on the Autism Spectrum

Journal of Clinical Practice in Speech-Language Pathology, 2022-03, Vol.24 (1), p.24-28

2022

Volltextzugriff (PDF)

Solid-phase biotinylation of antibodies

Journal of molecular recognition, 2004-05, Vol.17 (3), p.268-276

2004

Volltextzugriff (PDF)

An open label, multicenter phase II study combining imprime PGG (PGG) with pembrolizumab ( P ) in previously treated metastatic triple-negative breast cancer (mTNBC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2550-2550

2019

Volltextzugriff (PDF)

Histaminergic modulation in Tourette syndrome

Expert opinion on orphan drugs, 2016-02, Vol.4 (2), p.205-213

2016

Volltextzugriff (PDF)

Resources of Hope

Adults learning, 2009-10, Vol.21 (2), p.26

Cox, Joanna

2009

Volltextzugriff (PDF)

P859 Association of immunopharmacodynamic responses of imprime PGG plus pembrolizumab with clinical benefit in metastatic triple negative breast cancer (TNBC) subjects failing front-line chemotherapy

Journal for immunotherapy of cancer, 2020-04, Vol.8 (Suppl 1), p.A8-A9

2020

Volltextzugriff (PDF)

P862 Clinical benefit potentially evident with immunopharmacodynamic responses in prior-checkpoint failed metastatic melanoma patients treated with imprime PGG and pembrolizumab

Journal for immunotherapy of cancer, 2020-04, Vol.8 (Suppl 1), p.A10-A10

2020

Volltextzugriff (PDF)

Trypanosoma brucei plasma membrane-type Ca(2+)-ATPase 1 (TbPMC1) and 2 (TbPMC2) genes encode functional Ca(2+)-ATPases localized to the acidocalcisomes and plasma membrane, and essential for Ca(2+) homeostasis and growth

The Journal of biological chemistry, 2004-04, Vol.279 (14), p.14427-14439

2004

Volltextzugriff (PDF)

Falls and bradyarrhythmic disorders

Journal of the American College of Cardiology, 2002-03, Vol.39, p.133-133

2002

Volltextzugriff (PDF)

1 – 25 von 327

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(299)
Mit Volltextzugriff
(287)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(327)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Sensory aspects of Tourette syndrome

Aripiprazole for the treatment of Tourette syndrome

Social stigma and self-perception in adolescents with tourette syndrome

Irritability Symptoms in Gilles de la Tourette Syndrome

Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures

Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders

Telemedical education during national emergencies: learning from Kashmir

Audit of the management of the syphilis outbreak in Herefordshire 2011–2013

Zonisamide as a Treatment for Partial Epileptic Seizures: A Systematic Review

Clinical Guidelines on Long-Term Pharmacotherapy for Bipolar Disorder in Children and Adolescents

Abstract PD5-02: Dcis as a risk lesion for invasive breast cancer and death from other cancers

Trypanosoma brucei Plasma Membrane-Type Ca2+-ATPase 1 (TbPMC1) and 2 (TbPMC2) Genes Encode Functional Ca2+-ATPases Localized to the Acidocalcisomes and Plasma Membrane, and Essential for Ca2+ Homeostasis and Growth

Breaking the Stigma: Major Depressive Disorder

Abstract CT073: IMPRIME 1 (NCT02981303): A novel phase 2 study in second-line +, metastatic triple negative breast cancer patients shows promising clinical benefit for the combination of the immune checkpoint inhibitor, pembrolizumab (pembro), with the novel innate immune activator, Imprime PGG

The prevalence of growth hormone deficiency in survivors of subarachnoid haemorrhage: results from a large single centre study

Abstract PD1-02: Response and clinical benefit assessment of the combination of the dectin-1 agonist imprime PGG and anti-PD-1 pembrolizumab in chemotherapy-resistant metastatic triple negative breast cancer (TNBC)

The Biggest Difference in your Child’s Day: Parent-Identified Communication Challenges Experienced by their Children on the Autism Spectrum

Solid-phase biotinylation of antibodies

An open label, multicenter phase II study combining imprime PGG (PGG) with pembrolizumab ( P ) in previously treated metastatic triple-negative breast cancer (mTNBC)

Histaminergic modulation in Tourette syndrome

Resources of Hope

P859 Association of immunopharmacodynamic responses of imprime PGG plus pembrolizumab with clinical benefit in metastatic triple negative breast cancer (TNBC) subjects failing front-line chemotherapy

P862 Clinical benefit potentially evident with immunopharmacodynamic responses in prior-checkpoint failed metastatic melanoma patients treated with imprime PGG and pembrolizumab

Trypanosoma brucei plasma membrane-type Ca(2+)-ATPase 1 (TbPMC1) and 2 (TbPMC2) genes encode functional Ca(2+)-ATPases localized to the acidocalcisomes and plasma membrane, and essential for Ca(2+) homeostasis and growth

Falls and bradyarrhythmic disorders

Suchergebnisse filtern